Oral vinorelbine in young patients with desmoid-type fibromatosis.

Laure KornreichDaniel OrbachNayla NicolasHervé J BrissePablo BerlangaAnne-Sophie DefachellesLudovic MansuyCécile VeriteLaure SaumetMarie KaranianNadège Corradini

Published in: Tumori (2023)

Oral vinorelbine seems to be effective to control advanced or progressive desmoid type fibromatosis in young patients, with a well-tolerated profile. These results support testing this drug as first-line alone or in combination to improve response rate while preserving quality of life.

Keyphrases

middle aged
multiple sclerosis
phase ii study
radiation therapy
clinical trial
squamous cell carcinoma
open label
rectal cancer